Charlée Nardin

6PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 14, 2025
Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: a nationwide real-life study in France (NEOMEL).

Charlée Nardin, Charlotte Cavalieri, Céleste Lebbé

|Mar 04, 2025
Ipilimumab + nivolumab in combination vs. nivolumab monotherapy as first-line treatment in patients with metastatic melanoma: conclusions from a real-world French national cohort.

Charlée Nardin, Dewi Vernerey, François Aubin

|Feb 04, 2025
Malignant melanoma arising in a sebaceous naevus leading to the discovery of a pathogenic germline MUTYH mutation: a case report.

Aymeric Hennemann, Zohair Selmani, Alexis Perales

|Sep 09, 2023
Combined Nivolumab and Ipilimumab in Octogenarian and Nonagenarian Melanoma Patients.

Constance Reichert, Capucine Baldini, Sarah Mezghani

|Jul 29, 2023
Efficacy of Immune Checkpoint Inhibitor (ICI) Rechallenge in Advanced Melanoma Patients' Responders to a First Course of ICI: A Multicenter National Retrospective Study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée, GCC).

Charlée Nardin, Aymeric Hennemann, Kadiatou Diallo

|Oct 12, 2022
Cutaneous vasculitis associated with mycosis fungoides.

Charlée Nardin, Candice Lesage, Eléonore Goubeau

Pageof 1

Frequent Collaborators

2 joint publications

François Aubin

2 joint publications

Aymeric Hennemann

2 joint publications

Florence Brunet-Possenti

1 joint publications

Nicolas Ortonne